Table 1.
Individual times and locations of initial tablet disintegration (ITD) within the gastrointestinal tract of 153Sm-labelled MMX®-budesonide tablets
| Subject | ITD (h) | Location in the gastrointestinal tract |
|---|---|---|
| 01 | >24 | Sigmoid colon |
| 02 | 8.5–9 | Ascending colon |
| 03 | 12–24 | Ileum/ascending colon |
| 04 | 10–12 | Small intestine/ileum |
| 05 | 4–4.5 | Ileum/ascending colon |
| 06 | 10–12 | Ileum |
| 07 | 5.5–6 | Transverse colon |
| 08 | 7–7.5 | Small intestine/ileum |
| 09 | 6–6.5 | Ileum |
| 10 | 8–8.5 | Ileum/ascending colon |
| 11 | 9.5–10 | Transverse/descending colon |
| 12 | 6.5–7 | Ascending/transverse colon |